RECRUITING

A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.

Official Title

A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study

Quick Facts

Study Start:2022-01-05

Study Completion:2026-10-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05217108

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. \>18 years old; 2. owns a smart phone; 3. has access to WiFi or willing to use mobile data; 4. has an email address or willing to create an email address; 5. able to read and understand English; 6. able to give informed consent; 7. willing to receive text messages and complete brief questionnaires on their smart phone. 8. self-reports sedentary behavior (\> 6 hours/day of sitting time).	1. unwilling to have sedentary behavior and activity tracked 2. unable to walk without ambulatory assistance device (i.e. cane or walker) or due to underlying medical condition 3. MD Anderson employees that report to the Principal Investigators of this study 4. not sedentary based on \< 6 hours/day of sitting time.

Contacts and Locations

Study Contact

Karen Basen-Engquist, MD

CONTACT

(713) 745-3123

kbasenen@mdanderson.org

Principal Investigator

Karen Basen-Engquist, MD

PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center

Houston, Texas, 77030

United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

Karen Basen-Engquist, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-05

Study Completion Date2026-10-31

Study Record Updates

Study Start Date2022-01-05

Study Completion Date2026-10-31

Terms related to this study

Additional Relevant MeSH Terms

Life Style
Healthy Lifestyle